source
- Pharma marketers urged to adopt share-of-answer strategy as AI use surges among physiciansPharma marketers are planning for 2027 as artificial intelligence reshapes how clinicians seek clinical answers. The rise of AI tools means that traditional metrics like share of voice and broad om…
- Regenxbio gene therapy refiling plan derailed by FDA hold over spine MRI findingsThe FDA has put a clinical hold on Regenxbio’s RGX-121 over asymptomatic spine MRI findings, derailing the biotech’s plans to refile for approval of the once-rejected gene therapy candidate.Fierce Biotech · 7h ago↗ source
- Roche, Eli Lilly net FDA approval for first-of-its-kind Alzheimer’s biomarker blood test